Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of autologous nasal mucosal epithelial cell sheets for middle ear cholesteatoma (JMID01-02)
jRCT2033220518Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jan 2023
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous nasal mucosal epithelial cell sheet in Cholesteatoma and chronic otitis media (COM), sponsored by Japan Agency for Medical Research and Development. Started Jan 2023; status: completed.
02
Drugs
autologous nasal mucosal epithelial cell sheet
03
Conditions
Cholesteatomachronic otitis media (COM)
Beyond the preview
Go deeper on jRCT2033220518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033220518.